You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

List of Excipients in API FENOLDOPAM MESYLATE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing FENOLDOPAM MESYLATE

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Hospira Inc	CORLOPAM	fenoldopam mesylate	0409-2304	ANHYDROUS CITRIC ACID
Hospira Inc	CORLOPAM	fenoldopam mesylate	0409-2304	PROPYLENE GLYCOL
Hospira Inc	CORLOPAM	fenoldopam mesylate	0409-2304	SODIUM METABISULFITE
Hospira Inc	CORLOPAM	fenoldopam mesylate	0409-2304	TRISODIUM CITRATE DIHYDRATE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for FENOLDOPAM MESYLATE

Excipient focus: ANHYDROUS CITRIC ACID

FENOLDOPAM MESYLATE drug variants containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Hospira Inc	fenoldopam mesylate	0409-2304
Hospira Inc	fenoldopam mesylate	0409-3373
>Company	>Ingredient	>NDC

FENOLDOPAM MESYLATE drug variants not containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

FENOLDOPAM MESYLATE drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Hospira Inc	fenoldopam mesylate	0409-2304
Hospira Inc	fenoldopam mesylate	0409-3373
>Company	>Ingredient	>NDC

FENOLDOPAM MESYLATE drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM METABISULFITE

FENOLDOPAM MESYLATE drug variants containing SODIUM METABISULFITE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Hospira Inc	fenoldopam mesylate	0409-2304
Hospira Inc	fenoldopam mesylate	0409-3373
>Company	>Ingredient	>NDC

FENOLDOPAM MESYLATE drug variants not containing SODIUM METABISULFITE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRISODIUM CITRATE DIHYDRATE

FENOLDOPAM MESYLATE drug variants containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Hospira Inc	fenoldopam mesylate	0409-2304
Hospira Inc	fenoldopam mesylate	0409-3373
>Company	>Ingredient	>NDC

FENOLDOPAM MESYLATE drug variants not containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

FENOLDOPAM MESYLATE drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Hospira Inc	fenoldopam mesylate	0409-2304
Hospira Inc	fenoldopam mesylate	0409-3373
>Company	>Ingredient	>NDC

FENOLDOPAM MESYLATE drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.